| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Controladora Vuela (NYSE:VLRS) will release its quarterly earnings report on Tuesday, 2025-10-28. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate Controladora Vuela to report an earnings per share (EPS) of $-0.05.
The market awaits Controladora Vuela's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
In the previous earnings release, the company beat EPS by $0.19, leading to a 15.65% increase in the share price the following trading session.
Here's a look at Controladora Vuela's past performance and the resulting price change:
| Quarter | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| EPS Estimate | -0.73 | -0.54 | 0.53 | 0.21 |
| EPS Actual | -0.54 | -0.44 | 0.39 | 0.32 |
| Price Change % | 16.00 | -9.00 | -4.00 | -1.00 |
Shares of Controladora Vuela were trading at $6.85 as of October 24. Over the last 52-week period, shares are down 4.08%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release.
For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on Controladora Vuela.
The consensus rating for Controladora Vuela is Neutral, based on 5 analyst ratings. With an average one-year price target of $8.4, there's a potential 22.63% upside.
In this analysis, we delve into the analyst ratings and average 1-year price targets of Sun Country Airlines, Strata Critical Medical and Allegiant Travel, three key industry players, offering insights into their relative performance expectations and market positioning.
The peer analysis summary outlines pivotal metrics for Sun Country Airlines, Strata Critical Medical and Allegiant Travel, demonstrating their respective standings within the industry and offering valuable insights into their market positions and comparative performance.
| Company | Consensus | Revenue Growth | Gross Profit | Return on Equity |
|---|---|---|---|---|
| Frontier Group Holdings | Neutral | -4.52% | $5M | -13.01% |
| Sun Country Airlines | Outperform | 3.63% | $53.98M | 1.08% |
| Strata Critical Medical | Buy | 4.20% | $17.74M | -1.69% |
| Allegiant Travel | Neutral | 3.47% | $118.36M | -6.01% |
Key Takeaway:
Controladora Vuela ranks in the middle for Consensus rating among its peers. It is at the bottom for Revenue Growth. In terms of Gross Profit, Controladora Vuela is at the bottom compared to its peers. For Return on Equity, Controladora Vuela is also at the bottom among its peers.
Controladora Vuela Compania de Aviacion SAB de CV is a low-cost airline flying to Mexico, the United States, Central, and South America. It uses promotional fares to stimulate demand, and the base fares are priced to compete with long-distance bus fares in Mexico. Revenues from the air transportation of passengers are recognized earlier when the service is provided or when the non-refundable ticket expires on the date of the scheduled travel. Non-passenger revenues include revenues generated from other non-passenger services and cargo services. The Company has two geographic areas identified as domestic (Mexico) and international (United States of America, Central America, and South America).
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
Revenue Growth: Controladora Vuela's revenue growth over a period of 3 months has faced challenges. As of 30 June, 2025, the company experienced a revenue decline of approximately -4.55%. This indicates a decrease in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Industrials sector.
Net Margin: Controladora Vuela's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive -9.09% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Controladora Vuela's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of -22.14%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): Controladora Vuela's ROA excels beyond industry benchmarks, reaching -1.12%. This signifies efficient management of assets and strong financial health.
Debt Management: Controladora Vuela's debt-to-equity ratio stands notably higher than the industry average, reaching 14.96. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.
To track all earnings releases for Controladora Vuela visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: VLRS
